Skip to main content

Research Repository

Advanced Search

Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation

Gomzikova, Marina O.; James, Victoria; Rizvanov, Albert A.

Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation Thumbnail


Authors

Marina O. Gomzikova

Albert A. Rizvanov



Abstract

The immunosuppressive potential of mesenchymal stem cells has been extensively investigated in many studies in vivo and in vitro. In recent years, a variety preclinical and clinical studies have demonstrated that mesenchymal stem cells ameliorate immune-mediated disorders, including autoimmune diseases. However, to date mesenchymal stem cells have not become a widely used therapeutic agent due to safety challenges, high cost and difficulties in providing long term production. A key mechanism underpinning the immunomodulatory effect of MSCs is the production of paracrine factors including growth factors, cytokines, chemokines, and extracellular vesicles (EVs). MSCs derived EVs have become an attractive therapeutic agent for immunomodulation and treatment of immune-mediated disorders. In addition to many preclinical studies of MSCs derived EVs, their beneficial effects have been observed in patients with both acute graft-vs.-host disease and chronic kidney disease. In this review, we discuss the current findings in the field of MSCs derived EVs-based therapies in immune-mediated disorders and approaches to scale EV production for clinical use.

Citation

Gomzikova, M. O., James, V., & Rizvanov, A. A. (2019). Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation. Frontiers in Immunology, 10, https://doi.org/10.3389/fimmu.2019.02663

Journal Article Type Review
Acceptance Date Oct 28, 2019
Online Publication Date Nov 15, 2019
Publication Date Nov 15, 2019
Deposit Date Nov 20, 2019
Publicly Available Date Mar 29, 2024
Journal Frontiers in Immunology
Electronic ISSN 1664-3224
Publisher Frontiers Media
Peer Reviewed Peer Reviewed
Volume 10
Article Number 2663
DOI https://doi.org/10.3389/fimmu.2019.02663
Keywords Extracellular vesicles, Microvesicles, Immunosuppression, Autoimmune diseases, Multiple sclerosis, Transplant rejection, Type 1 diabetes, Graft-vs.-host disease
Public URL https://nottingham-repository.worktribe.com/output/3341277
Publisher URL https://www.frontiersin.org/articles/10.3389/fimmu.2019.02663/full

Files




You might also like



Downloadable Citations